Matches in SemOpenAlex for { <https://semopenalex.org/work/W2340508053> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2340508053 abstract "ABSTRACT Aim: Some clinical trials in breast cancer have reported imppressive outcomes related to laboratory immune findings in the neoadjuvant setting. In this context, tumor infiltrating lymphocytes (TILs) and regulatory Tcells (Tregs) in tissue specimens and in peripheral blood are being tested as two emerging prognostic and predictive factors. We designed a protocol to analyze immune profile before, during and after neoadjuvant chemotherapy (CT) in breast cancer in blood and tissue, and their eventual relation with pathological complete response (pCR). Methods: From March 2011 to february 2014, 47 patients (18 her2 + /29 her2-) with T2-4 N0-3 breast carcinoma treated wih neoadjuvant CT in the Breast Cancer Unit of the Hospital Universitario Virgen Macarena (Seville, Spain) were included in the study. CD3 + , CD8 + , CD8-16-56+ and FOXP3+ cell infiltrates were detected by immunohistochemistry before and after CT in tissue specimens. Blood samples were collected in EDTA-K3 tubes before every cycle to determine the immunophenotype profile. Cell populations were determined by flow cytometry analysis of whole blood, including the study of CD3-CD4-CD25low and CD3-CD4-C25high (regulatory) T cells. Results: By February 2014, 47 patients were operated. pCR or near pCR (grade 4/5 Miller&Payne) was attained in 20 patients (42,6%). pCR was achieved in 66,6% (12/18) of tumors overexpressing her2 and treated with CT plus trastuzumab, and in only a 27,5% (8/29) of the her2- population. Absence and /or disappearance of Tregs in tissue (Black grading system = 0) was more frequent after neoadjuvant CT (11,11 vs 62,2%). Furthermore, average whole blood CD3-CD4-CD25high (regulatory) T cells were 126,36 before and 91,19 after neoadjuvant CT (p 0,010). Overall Tregs diminished in the pCR and non pCR groups without statistically significant differences. Conclusions: Neoadjuvant CT decreases Tregs immunosuppressive infiltrates in tissue and CD3-CD4-CD25high (regulatory) T cells in peripheral blood in all the population. Although differences among subgroups (pCR/non-pCR and her-/her2+) were not statistically significant, these data support the role of Tregs as an interesting biomarker with eventual therapeutic implications in breast carcinoma. Disclosure: All authors have declared no conflicts of interest." @default.
- W2340508053 created "2016-06-24" @default.
- W2340508053 creator A5014613098 @default.
- W2340508053 creator A5036878096 @default.
- W2340508053 creator A5038461805 @default.
- W2340508053 creator A5048528021 @default.
- W2340508053 creator A5052670875 @default.
- W2340508053 creator A5069061103 @default.
- W2340508053 creator A5085278429 @default.
- W2340508053 date "2014-09-01" @default.
- W2340508053 modified "2023-10-18" @default.
- W2340508053 title "Pathological Complete Response and Changes Related to T Infiltrating Lymphocytes and Regulatory T Cells in Tissue and Peripheral Blood After Neoadjuvant Chemotherapy in Breast Carcinoma" @default.
- W2340508053 doi "https://doi.org/10.1093/annonc/mdu342.20" @default.
- W2340508053 hasPublicationYear "2014" @default.
- W2340508053 type Work @default.
- W2340508053 sameAs 2340508053 @default.
- W2340508053 citedByCount "0" @default.
- W2340508053 crossrefType "journal-article" @default.
- W2340508053 hasAuthorship W2340508053A5014613098 @default.
- W2340508053 hasAuthorship W2340508053A5036878096 @default.
- W2340508053 hasAuthorship W2340508053A5038461805 @default.
- W2340508053 hasAuthorship W2340508053A5048528021 @default.
- W2340508053 hasAuthorship W2340508053A5052670875 @default.
- W2340508053 hasAuthorship W2340508053A5069061103 @default.
- W2340508053 hasAuthorship W2340508053A5085278429 @default.
- W2340508053 hasBestOaLocation W23405080531 @default.
- W2340508053 hasConcept C121608353 @default.
- W2340508053 hasConcept C126322002 @default.
- W2340508053 hasConcept C142724271 @default.
- W2340508053 hasConcept C143998085 @default.
- W2340508053 hasConcept C167672396 @default.
- W2340508053 hasConcept C196166836 @default.
- W2340508053 hasConcept C203014093 @default.
- W2340508053 hasConcept C2778292576 @default.
- W2340508053 hasConcept C2778326572 @default.
- W2340508053 hasConcept C2779727006 @default.
- W2340508053 hasConcept C2779786085 @default.
- W2340508053 hasConcept C2908647359 @default.
- W2340508053 hasConcept C530470458 @default.
- W2340508053 hasConcept C553184892 @default.
- W2340508053 hasConcept C71924100 @default.
- W2340508053 hasConcept C8891405 @default.
- W2340508053 hasConcept C99454951 @default.
- W2340508053 hasConceptScore W2340508053C121608353 @default.
- W2340508053 hasConceptScore W2340508053C126322002 @default.
- W2340508053 hasConceptScore W2340508053C142724271 @default.
- W2340508053 hasConceptScore W2340508053C143998085 @default.
- W2340508053 hasConceptScore W2340508053C167672396 @default.
- W2340508053 hasConceptScore W2340508053C196166836 @default.
- W2340508053 hasConceptScore W2340508053C203014093 @default.
- W2340508053 hasConceptScore W2340508053C2778292576 @default.
- W2340508053 hasConceptScore W2340508053C2778326572 @default.
- W2340508053 hasConceptScore W2340508053C2779727006 @default.
- W2340508053 hasConceptScore W2340508053C2779786085 @default.
- W2340508053 hasConceptScore W2340508053C2908647359 @default.
- W2340508053 hasConceptScore W2340508053C530470458 @default.
- W2340508053 hasConceptScore W2340508053C553184892 @default.
- W2340508053 hasConceptScore W2340508053C71924100 @default.
- W2340508053 hasConceptScore W2340508053C8891405 @default.
- W2340508053 hasConceptScore W2340508053C99454951 @default.
- W2340508053 hasLocation W23405080531 @default.
- W2340508053 hasOpenAccess W2340508053 @default.
- W2340508053 hasPrimaryLocation W23405080531 @default.
- W2340508053 hasRelatedWork W2014154902 @default.
- W2340508053 hasRelatedWork W2104453868 @default.
- W2340508053 hasRelatedWork W2135298509 @default.
- W2340508053 hasRelatedWork W2313168486 @default.
- W2340508053 hasRelatedWork W2334410833 @default.
- W2340508053 hasRelatedWork W2460303553 @default.
- W2340508053 hasRelatedWork W2511814212 @default.
- W2340508053 hasRelatedWork W2635500302 @default.
- W2340508053 hasRelatedWork W2728363718 @default.
- W2340508053 hasRelatedWork W2774455292 @default.
- W2340508053 hasRelatedWork W2796105271 @default.
- W2340508053 hasRelatedWork W2900857942 @default.
- W2340508053 hasRelatedWork W2905469957 @default.
- W2340508053 hasRelatedWork W2947085112 @default.
- W2340508053 hasRelatedWork W2995903922 @default.
- W2340508053 hasRelatedWork W3018589088 @default.
- W2340508053 hasRelatedWork W3044945681 @default.
- W2340508053 hasRelatedWork W3135113890 @default.
- W2340508053 hasRelatedWork W3166045426 @default.
- W2340508053 hasRelatedWork W3211573659 @default.
- W2340508053 isParatext "false" @default.
- W2340508053 isRetracted "false" @default.
- W2340508053 magId "2340508053" @default.
- W2340508053 workType "article" @default.